Margarita del Val
Virologist and immunologist at the Severo Ochoa Centre for Molecular Biology, coordinator of the CSIC interdisciplinary research platform on Global Health.
The impetus for breakthroughs in research often comes when technological developments allow it. The development and commercialisation of messenger RNA vaccines against the covid-19 pandemic is a clear example of this. The 2023 Nobel Prize in Physiology recognises the long history of basic research by Dr. Katalin Karikó and Dr. Drew Weissman that has led to the optimal modification of messenger RNA and its delivery in lipid particles. Where necessary, basic knowledge has been applied to such a pressing need as the global pandemic emergency, which required rapid industrial development. These vaccines have succeeded in inducing such a strong immunity of protective activity in a large part of humanity that scientific research has enabled us to confront and, above all, overcome the pandemic.